Source: Motortion Films / Shutterstock.com
Enveric Biosciences (NASDAQ:ENVB) just reported results for the fourth quarter of 2023.
- Enveric Biosciences reported earnings per share of -$1.47. This was above the analyst estimate for EPS of -$1.54.
- The company did not report any revenue for the quarter.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/04/envb-stock-earnings-enveric-biosciences-for-q4-of-2023/.
©2024 InvestorPlace Media, LLC

